About the Store That Sells Nothing

What this site is

Wellness Peptide Store is an independent editorial digest covering NAD+ and Epitalon under the theme of longevity and cellular health. The name is deliberate: it takes the familiar storefront language and replaces the sales shelf with an evidence shelf. No compound, supplement, injectable, consultation, or referral is sold here. There is no cart and no preferred vendor.

The editorial frame is the wellness shelf, fact-checked. That means every major claim is pulled back to the kind of study underneath it. A mechanism observed in cultured cells stays a cell finding. A mouse result stays a mouse result. A blood biomarker in a human trial does not silently become proof of disease prevention or longer life. An observational association does not become causation. The goal is not to drain the subject of interest; it is to keep confidence proportional to evidence.

NAD+ and Epitalon make a useful pair because they expose two common category problems. NAD+ is not a peptide, even though it is routinely stocked beside them. Epitalon is a peptide, but its laboratory activity is routinely described with the certainty of a mature therapy. This digest corrects both without pretending the research questions are closed.

How to read the pages

Each technical page starts with a plain-English summary. Below it, the page separates identity, mechanism, research findings, community reports, cautions, and the compound's place in the broader theme. Numbered citations connect to one shared reference ledger. That structure makes it possible to check whether a sentence rests on a review, a randomized human trial, an animal model, cultured cells, or an observational cohort.

The comparison page uses four practical tests: What is the compound? What biological target does it engage? What is the strongest human evidence? What remains unshown? The answers matter more than a count of positive studies. Evidence maturity is about design, endpoint, replication, and directness—not volume of marketing copy.

Community experiences appear only when the composed research includes them, and they are labeled anecdotal, not clinical evidence. Anecdotes may identify questions worth studying, but they cannot prove efficacy or causation. Safety uncertainty is not tucked into a footer. It belongs beside the proposed benefit, where it can change how a reader interprets the claim.

Editorial boundaries

This is not a medical service. It does not diagnose, prescribe, recommend doses, design cycles, judge personal suitability, or interpret an individual symptom. It does not source research chemicals or evaluate sellers. NAD+-related products span supplements and compounded preparations with different evidence and quality-control issues. Epitalon has no approved human indication in major Western markets. Those facts make individualized guidance more—not less—dependent on a qualified professional and regulated context.

The source set is finite and visible. If a claim is not supported by that set, it does not belong in the digest. If the data are mixed, early, indirect, or limited to a model, the prose says so. Corrections are welcome through the editorial desk, especially when they identify a precise passage and a peer-reviewed source. The standard is simple: no glow, no scare tactics, no implied sale—just a usable account of what the literature can and cannot carry.